In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes
Abstract Background: The aminoglycoside antibiotic gentamicin is an ototoxic drug and has been used experimentally to investigate cochlear damage induced by noise. We have investigated the changes in the protein profile associated with caveolae in gentamicin treated and untreated spiral ligament (SL...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | inglés |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | http://eprints.uanl.mx/16314/1/159.pdf |
_version_ | 1824414573144309760 |
---|---|
author | Ghelfi, Elisa Grondin, Yohann Millet, Emil J. Bartos, Adam Bortoni, Magda Oliveira Gomes dos Santos, Clara Treviño Villarreal, Humberto J. Sepúlveda Sepúlveda, Rosalinda Rogers, Rick |
author_facet | Ghelfi, Elisa Grondin, Yohann Millet, Emil J. Bartos, Adam Bortoni, Magda Oliveira Gomes dos Santos, Clara Treviño Villarreal, Humberto J. Sepúlveda Sepúlveda, Rosalinda Rogers, Rick |
author_sort | Ghelfi, Elisa |
collection | Repositorio Institucional |
description | Abstract Background: The aminoglycoside antibiotic gentamicin is an ototoxic drug and has been used experimentally to investigate cochlear damage induced by noise. We have investigated the changes in the protein profile associated with caveolae in gentamicin treated and untreated spiral ligament (SL) pericytes, specialized cells in the blood labyrinth barrier of the inner ear microvasculature. Pericytes from various microvascular beds express caveolae, protein and cholesterol rich microdomains, which can undergo endocytosis and transcytosis to transport small molecules in and out the cells. A different protein profile in transport-specialized caveolae may induce pathological changes affecting the integrity of the blood labyrinth barrier and ultimately contributing to hearing loss. Method: Caveolae isolation from treated and untreated cells is achieved through ultracentrifugation of the lysates in discontinuous gradients. Mass spectrometry (LC-MS/MS) analysis identifies the proteins in the two groups. Proteins segregating with caveolae isolated from untreated SL pericytes are then compared to caveolae isolated from SL pericytes treated with the gentamicin for 24 h. Data are analyzed using bioinformatic tools. Results: The caveolae proteome in gentamicin treated cells shows that 40% of total proteins are uniquely associated with caveolae during the treatment, and 15% of the proteins normally associated with caveolae in untreated cell are suppressed. Bioinformatic analysis of the data shows a decreased expression of proteins involved in genetic information processing, and an increase in proteins involved in metabolism, vesicular transport and signal transduction in gentamicin treated cells. Several Rab GTPases proteins, ubiquitous transporters, uniquely segregate with caveolae and are significantly enriched in gentamicin treated cells. Conclusion: We report that gentamicin exposure modifies protein profile of caveolae from SL pericytes. We identified a pool of proteins which are uniquely segregating with caveolae during the treatment, mainly participating in metabolic and biosynthetic pathways, in transport pathways and in genetic information processing. Finally, we show for the first time proteins associated with caveolae SL pericytes linked to nonsyndromic hearing loss.
Keywords: Ototoxic drug, Nonsyndromic hearing loss, Rab GTPase, GOrilla enrichment analysis, Proteomaps |
format | Article |
id | eprints-16314 |
institution | UANL |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | eprints |
spelling | eprints-163142020-06-01T12:59:09Z http://eprints.uanl.mx/16314/ In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes Ghelfi, Elisa Grondin, Yohann Millet, Emil J. Bartos, Adam Bortoni, Magda Oliveira Gomes dos Santos, Clara Treviño Villarreal, Humberto J. Sepúlveda Sepúlveda, Rosalinda Rogers, Rick QP Fisiología Abstract Background: The aminoglycoside antibiotic gentamicin is an ototoxic drug and has been used experimentally to investigate cochlear damage induced by noise. We have investigated the changes in the protein profile associated with caveolae in gentamicin treated and untreated spiral ligament (SL) pericytes, specialized cells in the blood labyrinth barrier of the inner ear microvasculature. Pericytes from various microvascular beds express caveolae, protein and cholesterol rich microdomains, which can undergo endocytosis and transcytosis to transport small molecules in and out the cells. A different protein profile in transport-specialized caveolae may induce pathological changes affecting the integrity of the blood labyrinth barrier and ultimately contributing to hearing loss. Method: Caveolae isolation from treated and untreated cells is achieved through ultracentrifugation of the lysates in discontinuous gradients. Mass spectrometry (LC-MS/MS) analysis identifies the proteins in the two groups. Proteins segregating with caveolae isolated from untreated SL pericytes are then compared to caveolae isolated from SL pericytes treated with the gentamicin for 24 h. Data are analyzed using bioinformatic tools. Results: The caveolae proteome in gentamicin treated cells shows that 40% of total proteins are uniquely associated with caveolae during the treatment, and 15% of the proteins normally associated with caveolae in untreated cell are suppressed. Bioinformatic analysis of the data shows a decreased expression of proteins involved in genetic information processing, and an increase in proteins involved in metabolism, vesicular transport and signal transduction in gentamicin treated cells. Several Rab GTPases proteins, ubiquitous transporters, uniquely segregate with caveolae and are significantly enriched in gentamicin treated cells. Conclusion: We report that gentamicin exposure modifies protein profile of caveolae from SL pericytes. We identified a pool of proteins which are uniquely segregating with caveolae during the treatment, mainly participating in metabolic and biosynthetic pathways, in transport pathways and in genetic information processing. Finally, we show for the first time proteins associated with caveolae SL pericytes linked to nonsyndromic hearing loss. Keywords: Ototoxic drug, Nonsyndromic hearing loss, Rab GTPase, GOrilla enrichment analysis, Proteomaps BioMed Central 2018-03-16 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/16314/1/159.pdf http://eprints.uanl.mx/16314/1.haspreviewThumbnailVersion/159.pdf Ghelfi, Elisa y Grondin, Yohann y Millet, Emil J. y Bartos, Adam y Bortoni, Magda y Oliveira Gomes dos Santos, Clara y Treviño Villarreal, Humberto J. y Sepúlveda Sepúlveda, Rosalinda y Rogers, Rick (2018) In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes. Proteome Science, 16 (1). pp. 1-26. ISSN 1477-5956 http://doi.org/10.1186/s12953-018-0132-x doi:10.1186/s12953-018-0132-x |
spellingShingle | QP Fisiología Ghelfi, Elisa Grondin, Yohann Millet, Emil J. Bartos, Adam Bortoni, Magda Oliveira Gomes dos Santos, Clara Treviño Villarreal, Humberto J. Sepúlveda Sepúlveda, Rosalinda Rogers, Rick In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes |
thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
title | In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes |
title_full | In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes |
title_fullStr | In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes |
title_full_unstemmed | In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes |
title_short | In vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes |
title_sort | in vitro gentamicin exposure alters caveolae protein profile in cochlear spiral ligament pericytes |
topic | QP Fisiología |
url | http://eprints.uanl.mx/16314/1/159.pdf |
work_keys_str_mv | AT ghelfielisa invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT grondinyohann invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT milletemilj invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT bartosadam invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT bortonimagda invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT oliveiragomesdossantosclara invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT trevinovillarrealhumbertoj invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT sepulvedasepulvedarosalinda invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes AT rogersrick invitrogentamicinexposurealterscaveolaeproteinprofileincochlearspiralligamentpericytes |